Connected medical devices demand more than regulatory compliance. They require security engineered into every layer of the ecosystem. Zymr helps medical device manufacturers, digital health companies, hospitals, and IoMT platform providers build secure, FDA compliant connected products through secure by design engineering, threat modeling, penetration testing, SBOM management, and post market security operations. Combined with our Medical Device Software Development Services, IoMT Solutions, and Cloud Security Services, we help organizations protect connected devices throughout their lifecycle.


As medical devices become more connected, cyber risks continue to grow. Traditional security practices that focus on testing late in the development cycle are no longer enough. Organizations must now protect devices throughout their entire lifecycle while meeting evolving FDA cybersecurity requirements.
Modern medical device security combines secure engineering, continuous vulnerability management, SBOM governance, and post market monitoring into a single lifecycle strategy. Zymr helps medical device manufacturers, hospitals, and digital health companies build secure, compliant connected products by integrating cybersecurity across Medical Device Software Development Services and IoMT Solutions, from design through deployment and ongoing operations.
524B mandatory for cyber devices
FDA patch remediation expectation
device lifecycle security coverage
continuous vulnerability monitoring
Medical device cybersecurity is no longer just a product quality initiative. It has become a regulatory requirement. As connected devices exchange clinical data, connect to hospital networks, and receive software updates throughout their lifecycle, regulators now expect manufacturers to demonstrate how security is engineered into the product, not added after development.
This shift is reflected in FDA Section 524B, which introduced mandatory cybersecurity requirements for connected medical devices. Instead of relying on one-time penetration tests or documentation before launch, manufacturers must now establish secure development practices, maintain a Software Bill of Materials (SBOM), monitor vulnerabilities after deployment, and deliver security updates throughout the device's operational life.
A common misconception is that FDA cybersecurity compliance is simply another documentation exercise. In reality, documentation is only one outcome. The FDA expects organizations to prove that cybersecurity has been built into the architecture, software development lifecycle, risk management processes, and post market operations.

Meeting FDA Section 524B requires more than preparing submission documents. Manufacturers need a cybersecurity program that spans secure development, risk management, SBOMs, vulnerability management, and post market planning. Zymr helps organizations build engineering driven compliance strategies that support faster approvals and long term regulatory readiness.
Security should be built into the product from the first design decision, not added before release. Zymr integrates secure architecture reviews, threat modeling, secure coding practices, and DevSecOps throughout the software lifecycle, helping manufacturers reduce risk while accelerating product development.
Identifying vulnerabilities early reduces costly fixes later. Zymr performs structured threat modeling and penetration testing across firmware, applications, APIs, cloud platforms, and connected devices to validate security before products reach clinical environments.
Modern medical devices depend on open source and third party software components. Zymr helps organizations generate and maintain SBOMs, monitor newly disclosed vulnerabilities, and establish efficient remediation workflows that strengthen software supply chain security.
Cybersecurity responsibilities continue after product launch. Zymr establishes post market security operations, including continuous vulnerability monitoring, coordinated vulnerability disclosure, patch management, and incident response to help manufacturers protect deployed devices throughout their lifecycle.
Healthcare environments contain a mix of legacy and modern connected devices. Zymr secures these hybrid ecosystems through device risk assessments, network segmentation, secure integrations, and identity management, enabling organizations to improve security without replacing existing infrastructure.
Bringing a connected medical device to market requires more than functional validation. Manufacturers must demonstrate that cybersecurity has been considered throughout the design, development, and risk management process. Zymr helps engineering teams generate the technical evidence needed for successful regulatory submissions while embedding security into the product lifecycle from the start.
Zymr prepares technical artifacts for 510(k), De Novo, and PMA submissions, ensuring security evidence is complete, consistent, and aligned with current FDA expectations. This work naturally complements our Medical Device Software Development Services.
Cybersecurity risks must be evaluated alongside patient safety risks. We perform security risk assessments aligned with ISO 14971, helping manufacturers identify potential threats, assess their impact, and implement appropriate design controls before product release.
Security requirements should be traceable throughout development. Zymr integrates cybersecurity design controls into engineering workflows and quality management processes, helping organizations align with FDA QMSR requirements while reducing compliance gaps.
Regulators expect manufacturers to clearly demonstrate how device security has been engineered. We create architecture diagrams, trust boundaries, data flow models, and threat documentation that provide reviewers with clear visibility into the product's cybersecurity design.
We prepare customer facing security documentation, deployment guidance, maintenance recommendations, and security configuration instructions that help healthcare organizations operate connected devices securely.
cloud platforms, and APIs to uncover exploitable vulnerabilities before products reach healthcare environments. These assessments are delivered through our Penetration Testing Services.
Continuous vulnerability assessments help identify outdated software, insecure configurations, and known CVEs before they become operational risks. Our engineers prioritize findings based on business impact and remediation effort.
Firmware and communication interfaces are tested using automated fuzzing techniques to detect crashes, memory corruption, and unexpected behavior. This helps improve product stability while reducing the risk of firmware-level attacks.
Connected devices increasingly rely on Bluetooth Low Energy, Wi-Fi, NFC, and other wireless protocols. Zymr validates authentication, encryption, and communication security to protect devices from unauthorized access and wireless attacks.
Beyond individual vulnerabilities, we evaluate how attackers could compromise an entire connected medical device ecosystem. Red team engagements test people, processes, and technology to identify gaps before they can be exploited.
Security controls must perform as intended under real-world conditions. We verify encryption, authentication, access controls, secure updates, and regulatory security requirements through structured validation activities, complementing our Healthcare Software Testing Services and ensuring products are deployment ready.
We generate comprehensive Software Bills of Materials (SBOMs) using industry standards such as CycloneDX and SPDX, providing complete visibility into software components required for FDA submissions and ongoing security management.
Every external software component introduces potential risk. Zymr evaluates open source libraries and third party dependencies for licensing, security vulnerabilities, and lifecycle support, enabling manufacturers to make informed technology decisions.
Security teams need to know immediately when a newly disclosed CVE affects deployed products. We automate SBOM correlation with vulnerability databases to accelerate risk assessment and remediation planning. This capability integrates seamlessly with our Cloud Security Services for continuous monitoring.
We implement software integrity checks, component verification, dependency governance, and secure build pipelines to reduce supply chain risk while improving overall product resilience. These capabilities are further strengthened through our DevOps Services, enabling secure and repeatable software delivery.
We continuously monitor security advisories, CVEs, and emerging threats to identify vulnerabilities that may impact deployed devices. This enables engineering teams to assess risk quickly and prioritize remediation before issues affect customers.
An effective disclosure program enables manufacturers to receive, validate, and address reported vulnerabilities in a structured manner. Zymr helps establish CVD processes aligned with FDA guidance and international disclosure standards, improving transparency and response readiness.
Timely response is critical to reducing cybersecurity risk. We design vulnerability response workflows that streamline investigation, validation, patch development, and customer communication, helping organizations meet recommended disclosure and remediation timelines.
When security incidents occur, rapid containment is essential. Zymr develops incident response playbooks, forensic workflows, recovery procedures, and escalation processes to minimize operational disruption and protect patient safety. These capabilities integrate with our Threat Detection Systems expertise to improve response efficiency.
Deploying security updates safely is just as important as developing them. We engineer secure patch delivery processes, including firmware validation, rollback protection, staged deployments, and over the air updates to maintain device integrity while minimizing downtime.
Security performance should be continuously measured after deployment. Zymr helps manufacturers collect vulnerability data, maintain audit trails, generate regulatory evidence, and support ongoing post market reporting, ensuring security remains an active engineering function rather than a one time compliance exercise.
Every connected device should have a trusted identity. Zymr implements X.509 certificates, PKI infrastructure, and certificate lifecycle management to authenticate devices, prevent impersonation, and establish trusted communication across healthcare environments.
Edge gateways process sensitive clinical data before it reaches the cloud. We secure edge infrastructure through device hardening, secure access controls, encrypted storage, and runtime protection, helping reduce risks at the network edge.
Clinical data must remain protected throughout transmission. Zymr implements TLS, mTLS, certificate-based authentication, and secure API communication to safeguard data exchanged between medical devices, cloud platforms, and enterprise applications.
As connected devices integrate with EHRs and digital health platforms, API security becomes critical. We implement OAuth 2.0, OpenID Connect, mTLS, API gateways, and FHIR security controls to protect healthcare data while enabling secure interoperability.
Medical devices should never have unrestricted access to hospital networks. Zymr designs network segmentation strategies that isolate connected devices, reduce lateral movement, and limit the impact of potential security incidents.
Traditional perimeter security is no longer sufficient for connected healthcare environments. We implement Zero Trust principles by continuously verifying users, devices, and workloads before granting access, strengthening security across modern healthcare ecosystems.
We build machine learning models that establish normal device behavior and detect unusual activity that may indicate compromised devices, unauthorized access, or system misuse before traditional rule-based systems can identify it.
Our AI models continuously analyze device-to-device and device-to-cloud traffic to detect suspicious communication patterns, lateral movement, and other indicators of compromise. These capabilities align with our Threat Detection Systems expertise.
Managing thousands of connected devices requires centralized visibility. Zymr develops fleet-wide monitoring solutions that continuously assess device health, security posture, and emerging threats across distributed healthcare environments.
Every medical device has a predictable operating pattern. We establish behavioral baselines and generate intelligent alerts only when meaningful deviations occur, reducing false positives while enabling faster security investigations.
Zymr integrates global threat intelligence feeds with monitoring platforms to automatically identify newly emerging attack techniques, vulnerable software components, and indicators of compromise. These capabilities are further enhanced through our AI & ML Services, enabling proactive and adaptive medical device security.
Zymr applies AI-driven risk scoring to prioritize vulnerabilities and anomalous device behavior based on exploitability, clinical impact, and operational risk. This enables security teams to focus on the most critical threats first, improving response times and reducing alert fatigue.
We assess legacy medical devices to identify security gaps, unsupported software, outdated communication protocols, and configuration risks. These assessments help organizations prioritize remediation based on clinical and operational impact.
Many legacy devices cannot be patched or upgraded without affecting certification or patient care. Zymr implements compensating controls such as network isolation, virtual patching, access restrictions, and continuous monitoring to reduce risk without modifying the device itself.
Hospitals increasingly request Manufacturer Disclosure Statement for Medical Device Security (MDS2) documentation before deployment. We help manufacturers prepare and maintain accurate MDS2 documentation, enabling healthcare providers to evaluate device security and simplify procurement.
Zymr helps healthcare organizations build centralized inventories of connected medical devices, classify assets by risk, monitor device health, and prioritize remediation across large clinical environments. This capability aligns closely with our IoMT Solutions.
Flat hospital networks increase the risk of lateral movement during a cyberattack. We design microsegmentation strategies that isolate medical devices, restrict unnecessary communication, and contain threats before they impact critical clinical systems.
Zymr helps organizations develop phased modernization roadmaps that balance security improvements, regulatory requirements, budget constraints, and clinical continuity. Combined with our Medical Device Software Development Services, this approach enables a smooth transition toward a more secure and connected medical device ecosystem.
A cybersecurity SaaS provider needed to detect and respond to sophisticated threats across high-volume cloud environments. Zymr engineered an AI-powered threat detection platform on GCP using machine learning models, real-time analytics, and scalable cloud architecture to identify anomalous behavior with minimal latency. The same engineering principles can be applied to continuously monitor connected medical device fleets and detect emerging threats before they impact clinical operations.
Project Details →
A global cybersecurity company required a platform capable of collecting, correlating, and analyzing security events from thousands of distributed endpoints. Zymr engineered a centralized threat detection solution with automated alerting, policy management, and real-time security analytics, enabling faster incident response and improved operational visibility. These capabilities translate directly to post-market security operations for connected medical devices.
Project Details →
A large healthcare network required a secure IoMT platform to connect thousands of medical devices, including patient monitors, wearables, and infusion systems, across a multi-hospital environment. Zymr engineered a scalable platform that securely integrated connected devices, clinical systems, and analytics while enabling real-time monitoring and early sepsis detection. The engagement demonstrates our ability to secure connected medical device ecosystems at enterprise scale.
Project Details →
Developing connected medical devices requires balancing innovation, regulatory compliance, and product security. Zymr helps OEMs engineer secure-by-design devices with FDA 524B readiness, SBOM management, and lifecycle cybersecurity through our Medical Device Software Development Services.
Digital health applications rely on secure APIs, cloud infrastructure, and continuous software updates. We help SaMD providers secure applications, protect patient data, and meet evolving cybersecurity and regulatory requirements.
Hospitals manage thousands of connected and legacy medical devices across complex clinical environments. Zymr improves device security through network segmentation, continuous monitoring, and secure IoMT Solutions that minimize operational risk.
Diagnostic platforms process sensitive clinical data while integrating with EHRs and hospital systems. We secure device communications, APIs, and healthcare integrations to protect data across connected workflows.
Connected monitoring devices continuously exchange patient data between homes, mobile apps, and cloud platforms. Zymr engineers secure connectivity, encrypted communications, and scalable device security for modern RPM ecosystems.
High-risk medical devices demand security that protects both software integrity and patient safety. We implement secure firmware, authenticated updates, cryptographic controls, and continuous security validation throughout the product lifecycle.
IoMT platforms connect thousands of devices, applications, and cloud services. Zymr secures the entire ecosystem through device identity, API protection, AI-driven monitoring, and Cloud Security Services that safeguard connected healthcare environments.
This solution combines cybersecurity management plans, threat modeling, SBOM generation, security risk assessments, and submission-ready documentation into a structured engagement. It helps reduce approval delays while building a strong foundation for lifecycle security. This offering complements our Medical Device Software Development Services.
We integrate security into architecture, firmware, software, cloud platforms, and DevSecOps pipelines from day one. The result is faster development, lower remediation costs, and products engineered for long-term resilience. This solution aligns with our DevOps Services and Cloud Security Services.
Built for manufacturers, digital health companies, and healthcare providers, this engagement validates the security of connected devices, firmware, mobile applications, APIs, and cloud infrastructure. Organizations gain prioritized remediation guidance and independent security assurance before deployment.
This solution helps organizations establish complete visibility into software components across connected medical devices. We implement SBOM generation, vulnerability correlation, supply chain risk management, and continuous monitoring to simplify compliance while reducing software security risks throughout the product lifecycle.
Designed for manufacturers managing deployed medical devices, this solution provides continuous vulnerability monitoring, coordinated vulnerability disclosure, incident response, and secure patch management. Organizations can maintain regulatory readiness while reducing operational risk throughout the device lifecycle.
Healthcare organizations managing large connected device fleets need more than rule-based monitoring. We engineer AI-powered threat detection platforms that identify anomalous device behavior, prioritize security risks, and improve incident response using machine learning and behavioral analytics.
Representative Technologies: GitHub Actions, GitLab CI/CD, Jenkins, SonarQube, Snyk, Checkmarx, Veracode
Representative Technologies: X.509 Certificates, PKI, HSM, TPM, OpenSSL, HashiCorp Vault
Representative Technologies: OAuth 2.0, OpenID Connect (OIDC), mTLS, API Gateway, SMART on FHIR, FHIR R4/R5
Representative Technologies: Burp Suite, OWASP ZAP, Nessus, Metasploit, AFL++, Peach Fuzzer
Representative Technologies: CycloneDX, SPDX, Dependency-Track, Trivy, Grype, Syft
Representative Technologies: AWS Security Hub, Amazon GuardDuty, Microsoft Defender for Cloud, Google Security Command Center, Kubernetes, Istio
Representative Technologies: Splunk Enterprise Security, Microsoft Sentinel, Elastic Security, TensorFlow, PyTorch, OpenSearch, MITRE ATT&CK
Connected Medical Device Cybersecurity Services help manufacturers and healthcare organizations protect connected devices throughout their lifecycle. They include secure-by-design engineering, threat modeling, penetration testing, SBOM management, FDA cybersecurity compliance, and post-market security operations to reduce cyber risk and maintain regulatory readiness.
Manufacturers must demonstrate that cybersecurity has been incorporated into the product through secure development practices, risk assessments, threat modeling, SBOM documentation, cybersecurity management plans, and processes for monitoring and addressing future vulnerabilities.
A Software Bill of Materials (SBOM) is an inventory of the software components used within a medical device. It provides visibility into third-party and open-source dependencies, enabling manufacturers to quickly identify affected components when new vulnerabilities are disclosed
A Coordinated Vulnerability Disclosure program defines how manufacturers receive, investigate, prioritize, and resolve reported security vulnerabilities. It enables collaboration with researchers, customers, and regulators while reducing risks to deployed medical devices.
Commonly adopted standards include FDA Section 524B, IEC 81001-5-1, AAMI TIR57, IEC 62304, ISO 14971, ISO 13485, NIST CSF, MITRE ATT&CK, CycloneDX, SPDX, ISO/IEC 29147, and IEC 80001, depending on the product and regulatory requirements.
Our engagement models are tailored to each organization's needs. We offer project-based assessments, dedicated engineering teams, ongoing post-market security operations, and end-to-end product security engagements based on device complexity, regulatory scope, and business objectives.
FDA Section 524B establishes cybersecurity requirements for connected medical devices submitted for FDA review. A cyber device is a medical device that contains software, connects to networks or other systems, and requires cybersecurity controls to ensure its safe and secure operation throughout its lifecycle.
Manufacturers are expected to continuously monitor deployed devices for vulnerabilities, assess security risks, coordinate responsible disclosure, develop and validate patches, and communicate updates to customers. Cybersecurity is now an ongoing lifecycle responsibility rather than a one-time compliance activity.
Secure by Design means cybersecurity is incorporated into product architecture, software development, firmware, cloud infrastructure, and testing from the beginning rather than being added before release. This reduces remediation costs, improves product resilience, and supports regulatory compliance.
Legacy devices can often be protected through compensating controls such as network segmentation, device isolation, access control policies, continuous monitoring, and virtual patching. These measures reduce exposure without requiring hardware replacement.
Yes. Zymr secures devices, firmware, mobile applications, cloud platforms, APIs, EHR integrations, IoMT infrastructure, and hospital networks, enabling end-to-end protection across the connected healthcare ecosystem.
Zymr engineers medical device cybersecurity, secure-by-design SDLC, FDA 524B compliance, SBOM, penetration testing, post-market security operations, and AI threat detection, via GCC squads at 40–60% cost advantage.